A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome
Clinical trial NCT02257697 · COMPLETED
Trial details
- NCT number
- NCT02257697
- Sponsor
- Asahi Kasei Therapeutics Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2018-11-01
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.